Strategies to Increase the Use of Connected Insulin Pens Through Shared Decision-Making: A Quality Improvement Success Story
Increasing Access to Connected Insulin Pens by Promoting Shared Decision-Making Through Collaborative Quality Improvement
Partnering With Families Through Shared Decision-Making to Increase Connected Pen Use: A Quality Improvement Success Story
Increasing Awareness and Uptake of Connected Insulin Pens for Eligible Patients With Diabetes: A Quality Improvement Success Story
Depression Rates in Youth With Type 1 Diabetes During the COVID-19 Pandemic: Data From the T1D Exchange Quality Improvement Collaborative
Work from the T1D Exchange Quality Improvement Collaborative in the Spotlight at the ADA’s 84th Scientific Sessions
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) vs. Non-AID Insulin Pump for Newly Diagnosed People with Type 1 Diabetes Offers Improvement in Glycemic Control
Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real-World Data and Improvement Projects
Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries
Changes in HbA1c with GLP-1 Use in People with Type 1 Diabetes—Data from the T1D Exchange QI Initiative